Literature DB >> 736356

Responses to isoproterenol in a general population sample.

D B Lorber, W Kaltenborn, B Burrows.   

Abstract

The response of forced expiratory flow to inhalation of isoproterenol was evaluated in a general population sample of 1,063 subjects. Percentage changes in the forced expiratory volume in 1 sec and in the maximal flow measured at 50 percent of the initial expired forced vital capacity appeared to be the best indicators of responsiveness to bronchodilator. Subjects with a history of asthma more often showed responsiveness than did the remainder of the population, even when their initial function was within normal limits. Over-all, a high proportion of subjects with abnormalities in baseline forced expiratory volume in 1 sec or maximal flow after exhalation of 50 per cent of the forced vital capacity showed sufficient improvement after bronchodilator to cause their values after isoproterenol to fall within the normal range. The data suggest that responsiveness to bronchodilator aerosol may be a useful guide to the presence of bronchial reactivity in epidemiologic studies of obstructive airway diseases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 736356     DOI: 10.1164/arrd.1978.118.5.855

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  13 in total

1.  Pulmonary dysfunction in gold miners with reactive airways.

Authors:  R L Cowie
Journal:  Br J Ind Med       Date:  1989-12

Review 2.  Epidemiology of bronchial hyperresponsiveness.

Authors:  A J Woolcock; J K Peat
Journal:  Clin Rev Allergy       Date:  1989

3.  Defensiveness and individual response stereotypy in asthma.

Authors:  Jonathan M Feldman; Paul M Lehrer; Stuart M Hochron; Gary E Schwartz
Journal:  Psychosom Med       Date:  2002 Mar-Apr       Impact factor: 4.312

4.  Routine spirometric testing and COPD.

Authors:  B Burrows
Journal:  West J Med       Date:  1979-08

5.  Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.

Authors:  F D Martinez; P E Graves; M Baldini; S Solomon; R Erickson
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

6.  Diagnostic accuracy of the bronchodilator response in children.

Authors:  Sze Man Tse; Diane R Gold; Joanne E Sordillo; Elaine B Hoffman; Matthew W Gillman; Sheryl L Rifas-Shiman; Anne L Fuhlbrigge; Kelan G Tantisira; Scott T Weiss; Augusto A Litonjua
Journal:  J Allergy Clin Immunol       Date:  2013-05-14       Impact factor: 10.793

7.  Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials.

Authors:  Laura B Herpel; Richard E Kanner; Shing M Lee; Henry E Fessler; Frank C Sciurba; John E Connett; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2006-02-23       Impact factor: 21.405

8.  Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis.

Authors:  M Kattan; A Mansell; H Levison; M Corey; I R Krastins
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

9.  Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.

Authors:  P L Brand; P H Quanjer; D S Postma; H A Kerstjens; G H Koëter; P N Dekhuijzen; H J Sluiter
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

10.  Effect of breastfeeding on lung function in childhood and modulation by maternal asthma and atopy.

Authors:  Theresa W Guilbert; Debra A Stern; Wayne J Morgan; Fernando D Martinez; Anne L Wright
Journal:  Am J Respir Crit Care Med       Date:  2007-08-09       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.